Home LiteratureArticle Details
PMID: 13211907 Published · ppublish English Journal Article

A study of the chemical nature of components of bovine white matter effective in producing allergic encephalomyelitis in the rabbit.

The Journal of experimental medicine ·Vol. 100 ·No. 5 ·1954-11-01 ·Pages 451-71

WAKSMAN BH, PORTER H, LEES MD, ADAMS RD, FOLCH J

Abstract

Fractions of bovine white matter, prepared by the methods of Folch and Lees, were studied for chemical composition and for their ability to produce experimental allergic encephalomyelitis in rabbits. Evaluation of the disease and of the lesions in animals injected with the more active fractions at several dose levels permitted comparison of the antigenic activity of these materials. When tissue was fractionated by the methods of Folch and Lees, antigenic activity was found in the chloroform-methanol extract but not in the denatured tissue residue. This activity was traced to proteolipides A and B and to the lower phase, more specifically the ether-soluble fraction of the lower phase. Proteolipide C was inactive. Correlation of the chemistry of fractions with their antigenic activity suggested two possibilities: (a) that there might be two antigens, one proteolipide and the other non-proteolipide; or (b) that a small specific proteolipide is responsible for all the observed activity. The high concentration of acetal phosphatide in the ether-soluble lower phase suggested that compounds of this type might be the hypothetical non-proteolipide antigen, but this hypothesis was disproved by analytic study of active and inactive materials. The possibility that proteolipide might account for all the antigenic activity was strongly supported by the experimental finding that total lipide and proteolipide progressively lost activity as proteolipide was degraded by adequate processing. The use of an entirely different method for preparing total lipides free of proteolipide (the colloidal iron technique) indicated that this loss of activity did not result from incidental removal of some non-proteolipide antigen. These tentative conclusions are in agreement with those of Tal and Olitsky and provide a satisfactory interpretation of the findings of Goldstein et al. The very fact, however, that the suggested proteolipide antigen would amount to no more than 1 per cent of the total chloroform-methanol extractives leaves open the possibility that some unrecognized trace substance may be the antigen. Skin tests with the various fractions indicated some cross-reactivity between proteolipides A and B and the ether-soluble lower phase fraction and a fair correlation of positive skin reactions with disease. This finding is compatible with the suggestion that the same antigen is present in both of these types of material. When the disease produced by whole tissue or fractions was evaluated by the use of the proportion of animals developing disease, the day of onset, and the severity of the histologic lesions, it was found that fractions produced milder disease of later onset than intact tissue at all dose levels. The disease-producing activity was not enhanced by increasing the dose; i.e., it appeared to reach an asymptotic maximum below that obtainable with whole fresh tissue. This finding suggests both a quantitative loss of activity and a qualitative change during the initial chloroform-methanol extraction, a procedure which denatures all proteins in the tissue residue. A comparable change appeared to occur in whole white matter stored at -15 degrees C. for 15 months and thawed and refrozen several times during this period. The later fractionation steps resulted in no apparent loss of antigenic activity. A scoring method employing the same type of data to estimate the actual relative antigen contents of different preparations is presented in the Appendix.

Keywords
ANTIGENS AND ANTIBODIES BRAIN ENCEPHALOMYELITIS/experimental
MeSH Terms
Animals Antibodies Antigens Brain Cattle Encephalomyelitis Encephalomyelitis, Autoimmune, Experimental Rabbits White Matter
Chemicals
Antibodies Antigens
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
WAKSMAN B H
PORTER H
LEES M D
ADAMS R D
FOLCH J
References (21)
21 references, click to expand
  1. ALLERGIC ENCEPHALOMYELITIS IN MONKEYS IN RESPONSE TO INJECTION OF NORMAL MONKEY NERVOUS TISSUE.
    J Exp Med. 1947 Jan 1;85(1):131-40 PMID: 19871596
  2. THE RAPID PRODUCTION OF ACUTE DISSEMINATED ENCEPHALOMYELITIS IN RHESUS MONKEYS BY INJECTION OF HETEROLOGOUS AND HOMOLOGOUS BRAIN TISSUE WITH ADJUVANTS.
    J Exp Med. 1947 Jan 1;85(1):117-30 PMID: 19871595
  3. Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys.
    J Exp Med. 1948 Oct 1;88(4):417-26 PMID: 18884901
  4. Studies on the etiology and pathogenesis of experimental meningoencephalomyelitis in the guinea pig.
    J Immunol. 1949 Apr;61(4):355-67 PMID: 18127629
  5. Experimental disseminated encephalomyelitis in white mice.
    J Exp Med. 1949 Sep;90(3):213-24 PMID: 18137295
  6. THE WASSERMANN ANTIGEN AND RELATED "ALCOHOL-SOLUBLE" ANTIGENS.
    Bacteriol Rev. 1941 Dec;5(4):293-330 PMID: 16350073
  7. Acute disseminated encephalomyelitis following immunization with homologous brain extracts; studies on the role of a circulating antibody in the production of the condition in dogs.
    J Exp Med. 1950 Aug;92(2):133-52 PMID: 15428583
  8. The relationship of the demyelinating diseases to allergic encephalomyelitis.
    Medicine (Baltimore). 1950 May;29(2):99-121 PMID: 15416503
  9. Allergic encephalitis following injection of dialysate of brain tissue.
    Proc Soc Exp Biol Med. 1949 Nov;72(2):289-91 PMID: 15408342
  10. Relationship of homologous brain proteolipid to allergic encephalomyelitis in guinea pigs.
    Neurology. 1953 Aug;3(8):609-14 PMID: 13087581
  11. The chemical nature of encephalitogenic proteolipide A and B.
    Proc Soc Exp Biol Med. 1952 Dec;81(3):590-3 PMID: 13037730
  12. Quantitative studies on proteolipide as incitant of disseminated encephalomyelitis in mice.
    Science. 1952 Oct 17;116(3016):420-1 PMID: 12984134
  13. Studies on rabies. VII. Observations on the paralytogenic factor in rabies vaccine.
    Indian J Med Res. 1952 Jan;40(1):121-9 PMID: 14955293
  14. Experimental demyelination in relation to human and animal disease.
    Am J Med. 1952 May;12(5):547-60 PMID: 14933430
  15. Certain properties of the causal agent of experimental disseminated encephalomyelitis in mice.
    Proc Soc Exp Biol Med. 1951 Nov;78(2):607-10 PMID: 14911967
  16. Acute disseminated encephalomyelitis produced in mice by brain proteolipide (Folch-Lees).
    Proc Soc Exp Biol Med. 1952 Jan;79(1):50-3 PMID: 14892035
  17. Production of experimental encephalomyelitis with calcium acetate compound extracted from brain tissue.
    J Neuropathol Clin Neurol. 1951 Oct;10(4):394-407 PMID: 14874141
  18. Preparation of lipide extracts from brain tissue.
    J Biol Chem. 1951 Aug;191(2):833-41 PMID: 14861228
  19. Proteolipides, a new type of tissue lipoproteins; their isolation from brain.
    J Biol Chem. 1951 Aug;191(2):807-17 PMID: 14861226
  20. Tuberculin type sensitivity to spinal cord antigen in rabbits with isoallergic encephalomyelitis.
    J Immunol. 1951 Apr;66(4):421-44 PMID: 14824544
  21. Studies of acetal phospholipides of brain. I. Procedure of isolation of crystallized acetal phospholipide from brain.
    J Biol Chem. 1951 Jan;188(1):417-21 PMID: 14814152
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1954-11-01
Pages
451-71
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2136392
Subset
OM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com